pharmaphorum

JANUARY 12, 2023

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Drug diversion is the channelling of prescription drugs from a medical source into the illegal market.

Prescription 90

Prescription Healthcare Healthcare Medical 90

World of DTC Marketing

AUGUST 19, 2022

It’s no wonder that voters consistently rank bringing down prescription drug prices and other measures to reduce the cost of care as among Congress’ top priorities. Congress rightly chose to negioate drug prices for Medicare, but prescription drugs are only 10-12% of every healthcare dollar we spend.

Healthcare 204

Healthcare Healthcare Insurance Competition 204

PM360

JUNE 29, 2022

The line from the 2011 Pixar “Cars” sequel (trust me, as a parent of two, I have seen it countless times) points to the practical implication for voice technology. While this sort of innovation might not be a surprise in the automotive category, its breadth of functional benefits for patients and healthcare providers (HCPs) might be.

Marketing 96

Marketing Patients Healthcare Provider Prescription 96

PM360

OCTOBER 24, 2022

Through the GoodRx App, savings cards, and their website, GoodRx has saved Americans over $35 billion on prescriptions and avoid $60 million in hospitalization costs since 2011. GoodRx has recently created unique tools for healthcare providers to better care for their patients.

Insurance 40

Insurance Prescription Healthcare Healthcare 40

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Figure 1: Share of net spending for specialty and traditional prescription medications. The Uses—and Costs—of Specialty Treatments Keep Rising A U.S.

Prescription 52

Prescription Medical Patients Distribution 52

Pharmaceutical Technology

JANUARY 6, 2023

This class-action litigation specifically focused on a 2011 licensing agreement between the two companies. Ex-Novartis sales representative Steven Camburn filed a whistleblower case that claimed Novartis had paid doctors up to $3,500 to participate in educational speaker programs to increase the promotion and prescription of Gilenya.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97